Last News

On a behalf on an Italian company we are looking for new solutions in alternative to currently used anticoagulants to fight rodents (mice and rats).

Description of the Problem: We are looking for new solutions in alternative to currently used anticoagulants to fight rodents (mice and rats). More specifically, we are interested in identifying new substances to kill rodents. Anti-coagulant [...]

18 / 10 / 2016|

We have become coordinator of the PROGRESS-TT project

As of May 2, 2016, MITO Technology has become coordinator of PROGRESS-TT, an #H2020 project aimed at improving the transfer of technology from PROs to industry (www.progresstt.eu)

10 / 05 / 2016|

Microsoft acquires our client Solair

We are proud to report that our client Solair, a leading Italian company in the field of the Internet of Things led by Tom Davis, has been acquired by Microsoft. MITO was part of the [...]

5 / 05 / 2016|

We are hiring!

This position is open as part of the coordination team of an on-going Horizon 2020 project. The position of Junior Project Administrator is structured as follows: 2 consecutive days per week at the premises of [...]

22 / 03 / 2016|

MITO Technology has assisted Nice S.r.l. in the successful transaction that led Amazon Web Services to acquire the company

MITO Technology, the leading strategic IP and licensing company in Italy, has assisted Nice S.r.l. in the successful transaction that led Amazon Web Services to acquire the company. Nice is an Italian SME, located in [...]

7 / 03 / 2016|

Technology call: cardiovascolare

Per conto di una innovativa società tecnologica italiana, MITO Technology ricerca – con finalità di acquisizione o licenza – tecnologie brevettate nel settore cardiovascolare. Le tecnologie devono essere coperte da domanda di brevetto (con rapporto [...]

3 / 11 / 2015|

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Per saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta l' informativa estesa. Chiudendo questo banner, scorrendo la pagina, cliccando su qualsiasi link o comunque proseguendo la navigazione, acconsenti all’uso dei cookie.

Chiudi